US EditionPublished • loading... • Updated
Why Merck Is Sinking This Week
Summary by The Motley Fool
1 Articles
1 Articles
Why Merck Is Sinking This Week
Key PointsSales of blockbuster drug Keytruda missed expectations.The drug's patents will begin to expire in 2028.Merck also lowered revenue guidance for 2025.10 stocks we like better than Merck › The stock for pharmaceutical giant Merck (NYSE: MRK) was trading down more than 3% Monday morning. That's a big drop in just a few hours to start the week. So, what's going on?Where to invest $1,000 right now? Our analyst team just revealed what they be…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
